Radiotherapy for Head and Neck Squamous Cell Carcinoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 741
Special Issue Editors
Interests: head and neck squamous cell carcinoma; radiotherapy
Interests: head and neck cancer radiotherapy; cancer treatment in elderly; cancer and nutrition; radiomic; artificial intelligenge in head and neck cancer
Special Issue Information
Dear Colleagues,
Head and neck cancer comprises 4% of malignancies and is responsible for over 650,000 cases and 330,000 deaths globally. A team of medical professionals, including oncologists, radiologists, and surgical oncologists, work together to manage these conditions. Treatment options vary based on factors such as cancer type and stage, patient preferences, and potential side effects.
Radiation therapy is a key treatment for head and neck cancer, which can occur in various sites in the head and neck. Radiotherapy can be used alone or with other treatments, such as surgery and chemotherapy, to destroy cancer cells and reduce symptoms. Benefits of radiotherapy include preserving organ function, controlling pain, and being effective for patients unable to undergo surgery, although there can be side effects such as a dry mouth and skin irritation, which can be managed with supportive care. The use of AI in head and neck cancer radiotherapic treatment has shown promising results in optimizing and standardizing patient workflow. AI algorithms can help identify patterns and predict oncological and toxicity outcomes, leading to better clinical decision-making.
Chemoradiotherapy is the currently accepted treatment for locally advanced head and neck cancer, with the concomitant approach showing an increase in curability. HPV infection, alcohol, and tobacco use are recognized risk factors for head and neck cancers. HPV-related cancers tend to have a more favorable prognosis, resulting in intense treatments that may be unnecessary. Nevertheless, recent developments in radiotherapy, particularly intensity-modulated radiotherapy, molecular imaging-guided radiotherapy, adaptive radiotherapy, and proton therapy, can reduce the long-term toxicity of radiation therapy. Lastly, the immune system plays a vital role in fighting these cancers, and PD-1 blockade treatment has shown promising results for recurrent or metastatic head and neck cancers. In this Special Issue, we invite research papers, reviews, cancer biomarkers, and professional opinions that discuss the topic of locally advanced head and neck cancers.
Dr. Cesare Guida
Guest Editor
Ida D'Onofrio
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- head and neck squamous cell carcinoma
- radiotherapy
- biomarker
- chemoradiotherapy
- head and neck cancers
